Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyoshi Takeuchi

Showing results (11-20 of 203) with videos related to

Pageof 21
Sort By:
The Journal of Clinical Psychiatry|March 22, 2024
Does the Onset of Efficacy for Agitation Vary Depending on the Administration Route of Antipsychotics?Xintong Mu, Hiroyoshi Takeuchi
Psychopharmacology|June 6, 2013
A systematic review of reported cases involving psychotic symptoms worsened by aripiprazole in schizophrenia or schizoaffective disorderHiroyoshi Takeuchi, Gary Remington
Behavioural Brain Research|January 8, 2021
Dose-dependent effects of antipsychotics on efficacy and adverse effects in schizophreniaKazunari Yoshida, Hiroyoshi Takeuchi
Psychiatry and Clinical Neurosciences|January 26, 2023
Does short-term antipsychotic discontinuation of up to 3 weeks worsen symptoms in acute schizophrenia? A pooled analysis of placebo washout dataHiroyoshi Takeuchi, Kei Watabe
Brain and Nerve = Shinkei Kenkyu No Shinpo|May 17, 2023
[Pharmacological Treatment of Tardive Dyskinesia]Keisuke Kusudo, Hiroyoshi Takeuchi
Journal of Clinical Psychopharmacology|December 2, 2024
Efficacy and Safety of Dose Increase From 40 mg/d to 80 mg/d of Lurasidone in Patients With Schizophrenia: A Post Hoc Analysis of Extension TrialHiroyoshi Takeuchi, Hiroyuki Uchida
CNS Drugs|November 20, 2019
Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction AlgorithmChen-Chung Liu, Hiroyoshi Takeuchi
Journal of Clinical Psychopharmacology|October 20, 2015
Effect of Antipsychotic Dosing Regimen on Neurocognition in SchizophreniaHiroyoshi Takeuchi, Gagan Fervaha, Gary Remington
Therapeutic Advances in Psychopharmacology|January 5, 2023
Current perspectives on the epidemiology and burden of tardive dyskinesia: a focused review of the clinical situation in JapanYasuhiro Mori, Hiroyoshi Takeuchi, Yuichiro Tsutsumi
Asian Journal of Psychiatry|January 10, 2024
Involuntary administration of long-acting injectable antipsychotics in hospitalized patients with schizophrenia who are incapable of providing informed consentFuminari Misawa, Yasuo Fujii, Hiroyoshi Takeuchi
Pageof 21

Showing results (11-20 of 203) with videos related to

Sort By:
Pageof 21
The Journal of Clinical Psychiatry|March 22, 2024
Does the Onset of Efficacy for Agitation Vary Depending on the Administration Route of Antipsychotics?Xintong Mu, Hiroyoshi Takeuchi
Psychopharmacology|June 6, 2013
A systematic review of reported cases involving psychotic symptoms worsened by aripiprazole in schizophrenia or schizoaffective disorderHiroyoshi Takeuchi, Gary Remington
Behavioural Brain Research|January 8, 2021
Dose-dependent effects of antipsychotics on efficacy and adverse effects in schizophreniaKazunari Yoshida, Hiroyoshi Takeuchi
Psychiatry and Clinical Neurosciences|January 26, 2023
Does short-term antipsychotic discontinuation of up to 3 weeks worsen symptoms in acute schizophrenia? A pooled analysis of placebo washout dataHiroyoshi Takeuchi, Kei Watabe
Brain and Nerve = Shinkei Kenkyu No Shinpo|May 17, 2023
[Pharmacological Treatment of Tardive Dyskinesia]Keisuke Kusudo, Hiroyoshi Takeuchi
Journal of Clinical Psychopharmacology|December 2, 2024
Efficacy and Safety of Dose Increase From 40 mg/d to 80 mg/d of Lurasidone in Patients With Schizophrenia: A Post Hoc Analysis of Extension TrialHiroyoshi Takeuchi, Hiroyuki Uchida
CNS Drugs|November 20, 2019
Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction AlgorithmChen-Chung Liu, Hiroyoshi Takeuchi
Journal of Clinical Psychopharmacology|October 20, 2015
Effect of Antipsychotic Dosing Regimen on Neurocognition in SchizophreniaHiroyoshi Takeuchi, Gagan Fervaha, Gary Remington
Therapeutic Advances in Psychopharmacology|January 5, 2023
Current perspectives on the epidemiology and burden of tardive dyskinesia: a focused review of the clinical situation in JapanYasuhiro Mori, Hiroyoshi Takeuchi, Yuichiro Tsutsumi
Asian Journal of Psychiatry|January 10, 2024
Involuntary administration of long-acting injectable antipsychotics in hospitalized patients with schizophrenia who are incapable of providing informed consentFuminari Misawa, Yasuo Fujii, Hiroyoshi Takeuchi
Pageof 21